Johnson Johnson

JPMorgan's Michael Weinstein upgraded shares of Johnson & Johnson (NYSE: JNJ) from Neutral to Overweight with a price target boosted from $133 to $140 despite underperformance over the past year. According to Weinstein, shares of JNJ have underperformed the past 12 months and showed investors...